Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country
Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of ph...
Gespeichert in:
Veröffentlicht in: | International journal of environmental research and public health 2020-03, Vol.17 (7), p.2209 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | 2209 |
container_title | International journal of environmental research and public health |
container_volume | 17 |
creator | Hussain, Rabia Hassali, Mohamed Azmi Ur Rehman, Anees Muneswarao, Jaya Hashmi, Furqan |
description | Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system. |
doi_str_mv | 10.3390/ijerph17072209 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7178000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2635380233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0Eom3gyhFZ4lAuW_yx3vVyqBRFBSoFESR6thx7nDjatYO9m5L_vkYtVctprPFvxn7vIfSOkgvOO_LJ7yDtt7QlLWOke4FOadOQqm4IffnkfILOct4RwmXddK_RCWeMSi7EKbpdbY_ZG69DPsc3wULKow7Whw0uBa-SNqM3kHF0eLXVadAmHvzG9zoY-Ix_Trr3ox79AfDVnz0kD6WPXYoDnuNlvIWEv3tre6iug4kD4EWcwpiOb9Arp_sMbx_qDN18ufq1-FYtf3y9XsyXlampHCsJ1glq1lw2RtOWacM7QZkUrpZAmSNCWCvd2hpNJMC6psUFKhrWaeHaRvMZurzfu5_WA1gD5XHdq33yg05HFbVXz2-C36pNPKiWtpIUx2bo48OCFH9PkEc1-GygLwZAnLJixVNGBCOyoB_-Q3dxSqHIU6zhgkvCOC_UxT1lUsw5gXv8DCXqb6bqeaZl4P1TCY_4vxD5HfHAoB0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2635380233</pqid></control><display><type>article</type><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</creator><creatorcontrib>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</creatorcontrib><description>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph17072209</identifier><identifier>PMID: 32218355</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Content analysis ; Data collection ; Developed countries ; Drug stores ; Familiarity ; Health care ; Hospitals ; Interviews ; Knowledge ; Legal liability ; Medical personnel ; Participation ; Pharmacology ; Pharmacovigilance ; Physicians ; Qualitative research ; Research methodology ; Side effects ; Therapeutic drug monitoring</subject><ispartof>International journal of environmental research and public health, 2020-03, Vol.17 (7), p.2209</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</citedby><cites>FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</cites><orcidid>0000-0002-6502-8464 ; 0000-0001-8183-0855</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178000/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178000/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32218355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hussain, Rabia</creatorcontrib><creatorcontrib>Hassali, Mohamed Azmi</creatorcontrib><creatorcontrib>Ur Rehman, Anees</creatorcontrib><creatorcontrib>Muneswarao, Jaya</creatorcontrib><creatorcontrib>Hashmi, Furqan</creatorcontrib><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><title>International journal of environmental research and public health</title><addtitle>Int J Environ Res Public Health</addtitle><description>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</description><subject>Content analysis</subject><subject>Data collection</subject><subject>Developed countries</subject><subject>Drug stores</subject><subject>Familiarity</subject><subject>Health care</subject><subject>Hospitals</subject><subject>Interviews</subject><subject>Knowledge</subject><subject>Legal liability</subject><subject>Medical personnel</subject><subject>Participation</subject><subject>Pharmacology</subject><subject>Pharmacovigilance</subject><subject>Physicians</subject><subject>Qualitative research</subject><subject>Research methodology</subject><subject>Side effects</subject><subject>Therapeutic drug monitoring</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc1vEzEQxS0Eom3gyhFZ4lAuW_yx3vVyqBRFBSoFESR6thx7nDjatYO9m5L_vkYtVctprPFvxn7vIfSOkgvOO_LJ7yDtt7QlLWOke4FOadOQqm4IffnkfILOct4RwmXddK_RCWeMSi7EKbpdbY_ZG69DPsc3wULKow7Whw0uBa-SNqM3kHF0eLXVadAmHvzG9zoY-Ix_Trr3ox79AfDVnz0kD6WPXYoDnuNlvIWEv3tre6iug4kD4EWcwpiOb9Arp_sMbx_qDN18ufq1-FYtf3y9XsyXlampHCsJ1glq1lw2RtOWacM7QZkUrpZAmSNCWCvd2hpNJMC6psUFKhrWaeHaRvMZurzfu5_WA1gD5XHdq33yg05HFbVXz2-C36pNPKiWtpIUx2bo48OCFH9PkEc1-GygLwZAnLJixVNGBCOyoB_-Q3dxSqHIU6zhgkvCOC_UxT1lUsw5gXv8DCXqb6bqeaZl4P1TCY_4vxD5HfHAoB0</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Hussain, Rabia</creator><creator>Hassali, Mohamed Azmi</creator><creator>Ur Rehman, Anees</creator><creator>Muneswarao, Jaya</creator><creator>Hashmi, Furqan</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6502-8464</orcidid><orcidid>https://orcid.org/0000-0001-8183-0855</orcidid></search><sort><creationdate>20200325</creationdate><title>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</title><author>Hussain, Rabia ; Hassali, Mohamed Azmi ; Ur Rehman, Anees ; Muneswarao, Jaya ; Hashmi, Furqan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-8edf51cb386ca172ac3951285f48e12f055dd8fbdca08eeb4120915629a5f76a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Content analysis</topic><topic>Data collection</topic><topic>Developed countries</topic><topic>Drug stores</topic><topic>Familiarity</topic><topic>Health care</topic><topic>Hospitals</topic><topic>Interviews</topic><topic>Knowledge</topic><topic>Legal liability</topic><topic>Medical personnel</topic><topic>Participation</topic><topic>Pharmacology</topic><topic>Pharmacovigilance</topic><topic>Physicians</topic><topic>Qualitative research</topic><topic>Research methodology</topic><topic>Side effects</topic><topic>Therapeutic drug monitoring</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussain, Rabia</creatorcontrib><creatorcontrib>Hassali, Mohamed Azmi</creatorcontrib><creatorcontrib>Ur Rehman, Anees</creatorcontrib><creatorcontrib>Muneswarao, Jaya</creatorcontrib><creatorcontrib>Hashmi, Furqan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussain, Rabia</au><au>Hassali, Mohamed Azmi</au><au>Ur Rehman, Anees</au><au>Muneswarao, Jaya</au><au>Hashmi, Furqan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country</atitle><jtitle>International journal of environmental research and public health</jtitle><addtitle>Int J Environ Res Public Health</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>17</volume><issue>7</issue><spage>2209</spage><pages>2209-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Developed countries have established pharmacovigilance systems to monitor the safety of medicines. However, in the developing world, drug monitoring and reporting are facing enormous challenges. The current study was designed to explore the challenges related to the understanding and practices of physicians in reporting adverse drug reactions in Lahore, Pakistan. Through the purposive sampling technique, 13 physicians were interviewed. All interviews were audio-recorded, transcribed verbatim, and analyzed for a thematic content analysis. The thematic content analysis yielded six major themes: (1) Familiarity with medication safety and adverse drug reaction (ADR) concept, (2) Knowledge about pharmacovigilance activities, (3) Practices related to ADR reporting, (4) Barriers impeding ADR reporting, (5) Acknowledgement of the pharmacist's role, and (6) System change needs. The majority of the physicians were unaware of the ADR reporting system; however, they were ready to accept practice changes if provided with the required skills and training. A lack of knowledge, time, and interest, a fear of legal liability, poor training, inadequate physicians' and other healthcare professionals' communication, and most importantly lack of a proper reporting system were reported as barriers. The findings based on emerging themes can be used to establish an effective pharmacovigilance system in Pakistan. Overall, physicians reported a positive attitude towards practice changes, provided the concerned authorities support and take interest in this poorly acknowledged but most needed component of the healthcare system.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32218355</pmid><doi>10.3390/ijerph17072209</doi><orcidid>https://orcid.org/0000-0002-6502-8464</orcidid><orcidid>https://orcid.org/0000-0001-8183-0855</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-4601 |
ispartof | International journal of environmental research and public health, 2020-03, Vol.17 (7), p.2209 |
issn | 1660-4601 1661-7827 1660-4601 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7178000 |
source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Content analysis Data collection Developed countries Drug stores Familiarity Health care Hospitals Interviews Knowledge Legal liability Medical personnel Participation Pharmacology Pharmacovigilance Physicians Qualitative research Research methodology Side effects Therapeutic drug monitoring |
title | Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A42%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physicians'%20Understanding%20and%20Practices%20of%20Pharmacovigilance:%20Qualitative%20Experience%20from%20A%20Lower%20Middle-Income%20Country&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Hussain,%20Rabia&rft.date=2020-03-25&rft.volume=17&rft.issue=7&rft.spage=2209&rft.pages=2209-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph17072209&rft_dat=%3Cproquest_pubme%3E2635380233%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2635380233&rft_id=info:pmid/32218355&rfr_iscdi=true |